Genelux revenue was $8.00k for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2024) ending on Sep 30, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, GNLX annual revenue was $170.0k, with -98.5% growth year-over-year.
GNLX past revenue growth
How has GNLX's revenue growth performed historically?
Genelux (NASDAQ: GNLX) reported Q3 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Genelux's revenue was $0.00.
What was Genelux's revenue in 2023?
Genelux's annual revenue for the twelve months ending Dec 31, 2023 was $170.00 thousand, a 98.46% decrease year over year.
How much does Genelux make in a day?
Based on Genelux annual revenue for the past three years, GNLX makes an average of $10,263.01 per day.
What was Genelux's annual revenue growth in the past year?
As of Q4 2024, Genelux's revenue has grown -96.64% year over year. This is 1,242.17 percentage points lower than the US Biotechnology industry revenue growth rate of 1,145.53%. Genelux's revenue in the past year totaled $8.00 thousand.
How much does Genelux make in a year?
Genelux's revenue by year for the past three years is:
Genelux's revenue for the twelve months ending Dec 31, 2023 was $170.00 thousand, a 98.46% decrease year over year.
Genelux's annual revenue for Dec 31, 2022 was $11.07 million, a Infinity% increase from 2021.
Genelux's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.